JAMA examines history of HIV testing

	Tweet

"HIV Screening in Health Care Settings: Public Health and Civil Liberties Conflict?” Journal of the American Medical Association: Lawrence Gostin, associate dean at the Georgetown University Law Center, in the Oct. 25 issue of JAMA examines the history of HIV testing and the new CDC recommendations regarding testing.

According to Gostin, policies for HIV screening began in the 1980s, “when the scientific and social context was markedly different than it is today” because “rudimentary” treatments meant that people were “unlikely to benefit from HIV testing.”

In “vulnerable communities,” a “public health model” for fighting the spread of HIV would address their “health and collective well-being” and not focus solely on their rights, Gostin writes, adding that as the personal and social benefits of HIV testing increase and the social risks of being HIV-positive decrease, a public health strategy “appears warranted.”

According to Gostin, CDC—which supported a “‘rights approach” for decades—is “moving demonstrably toward public health” state laws that “could stand as a barrier” to the implementation of CDC’s guidelines.

For instance, the training and certification required to perform HIV testing could limit hospitals and physician and dental offices from providing the services, and laws that require pretest counseling with prescribed content areas might hinder HIV testing.

In addition, state laws that require informed consent and post-test activities—such as counseling and confirmatory tests in licensed laboratories—might limit testing.

“If states do not reform their laws, they may pose insuperable obstacles to routine screening,” Gostin writes, adding, “State law reform, therefore, is critical if the CDC is to fully achieve its objectives.”

Gostin also writes that protecting health care workers from legal liability surrounding testing recommendations “poses yet another legal dilemma.”

If health care professionals fail to offer HIV tests according to CDC recommendations, they could be found negligent, according to Gostin.

If a health care professional conducts an HIV test and knows that the patient’s partners are at risk, not protecting those partners “could result in liability,” Gostin writes (Gostin, JAMA, 10/25).

RELATED STORIES:
FDA Advisory Panel Approves Home HIV Test Kit   FDA Approves New In-Home HIV Test   Home HIV test advances   Survey Reveals Support for Over-the Counter HIV Testing   F.D.A. Panel Weighs Preventive Use of H.I.V. Drug   Stem Cell Therapy Shows Promise in Fight Against HIV   Progress against HIV thwarted by patients’ unmet needs   California to test pill for HIV prevention   Mechanism of HIV spread has potential for future drug therapy   Seeking HIV treatment clues in the neem tree   HIV Prevention Pill’s Value Varies by Target   Using AIDS drugs to prevent infection: a bargain?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]